AI-Driven QSAR & Virtual Screening Pipeline for Anti-Cancer Scaffold Discovery
ğŸ“Œ Overview

This project implements an end-to-end computational drug discovery pipeline integrating:

Cheminformatics (RDKit)

Machine Learning (Scikit-learn, TensorFlow)

Model Interpretability (SHAP)

Molecular Docking (AutoDock Vina)

The pipeline predicts compound activity (ICâ‚…â‚€), toxicity, and drug-likeness, and integrates docking scores to prioritize anti-cancer scaffolds targeting Caspase-9, BCL-2, and VEGF.

âš™ï¸ Workflow

Data preprocessing (SMILES canonicalization, duplicate removal)

Molecular descriptor generation (MW, LogP, TPSA, HBD/HBA, CSP3)

2048-bit Morgan fingerprint generation (radius=2)

Regression modeling (ICâ‚…â‚€ prediction)

Toxicity classification with SMOTE balancing

Deep learning regression (LogP prediction)

SHAP-based model interpretability

Docking score integration & consensus scoring

ğŸ“Š Model Performance
Random Forest Regressor

Test RÂ² = 0.929

Train RÂ² = 0.925

Strong generalization

5-fold GridSearchCV (540 fits)

HistGradientBoosting

Test RÂ² = 0.753

Toxicity Classifier

Accuracy = 95%

AUC-ROC = 0.959

Stratified K-fold cross-validation (mean accuracy = 0.99)

Neural Network

Architecture: 8 â†’ 64 â†’ 32 â†’ 1

Test MAE â‰ˆ 0.83

Convergence within 30 epochs

ğŸ”¬ Feature Importance (SHAP)

Top predictors:

MolLogP

Molecular Weight

Indicating lipophilicity and size dominate bioactivity prediction.

ğŸ§ª Docking Integration

Docking performed using AutoDock Vina.

Consensus filtering:

Docking score < -7.0 kcal/mol

High ML-predicted activity

Favorable ADMET profile

Identified promising scaffolds:

Benzothiazole

Citral

Thiophene (optimization required)

ğŸš€ Key Technical Contributions

End-to-end reproducible ML pipeline

Hyperparameter optimization

SMOTE class balancing

SHAP explainability

ML + docking hybrid modeling

Robust cross-validation strategy

ğŸ›  Tech Stack

Python

RDKit

Scikit-learn

TensorFlow

SHAP

AutoDock Vina

Google Colab
